CMI_LatestReportOrientedBlogs

  Blood Banking Devices Blood transfusion, a procedure used to treat a variety of medical disorders, replenishes lost blood components and improves the patient's health. However, a lack of timely access to safe blood transfusions will raise demand for blood banks to provide efficient, safe, and real-time blood unit availability. According to Coherent Market Insights, The global Blood Banking Devices Market was valued at US$ 26,234 Mn in 2017 and is expected to witness a CAGR of 7.4% over the forecast period (2018 – 2026). Various companies are engaged in initiatives aimed at bringing new product solutions to market. For example, in March 2018, Strides Software Solutions, an India-based company that facilitates the availability of safe and high-quality blood components, released D-Health, India's first Aadhaar-based centralised donor verification and identity app. This programme uses cloud computing to connect all of the important parties in blood cycle management together

myelofibrosis treatment  Myelofibrosis is a rare genetic disorder that affects the bone marrow. It is caused by a malfunction of the immune system. As a result, the body becomes infected with abnormal cytokines. This faulty immune system causes inflammation and results in the development of blood clots. These clots can occur in the brain, the eyes, the heart, and the veins in the legs, known as deep vein thrombosis. The progression of the disease is classified into three stages. Immunotherapy is one of the popular type of myelofibrosis treatment method. Limited awareness of the novel therapies and high costs involved in treatment are the factors restricting the growth of the global Myelofibrosis Treatment market. Symptoms may not begin immediately, as one-third of people with myelofibrosis have no symptoms when first diagnosed. The condition typically develops over time as the abnormal cells increase in number and the healthy ones decrease. Among the most common symptoms of this dis